Your browser doesn't support javascript.
loading
Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
Ramirez, Santseharay; Fernandez-Antunez, Carlota; Mikkelsen, Lotte S; Pedersen, Jannie; Li, Yi-Ping; Bukh, Jens.
Affiliation
  • Ramirez S; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark santseharayra@sund.ku.dk jbukh@sund.ku.dk.
  • Fernandez-Antunez C; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mikkelsen LS; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.
  • Pedersen J; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Li YP; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.
  • Bukh J; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Article in En | MEDLINE | ID: mdl-31818814

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pyrrolidines / Quinoxalines / Sulfonamides / Benzimidazoles / Carbamates / Viral Nonstructural Proteins / Hepacivirus / Drug Resistance, Viral / Sofosbuvir Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pyrrolidines / Quinoxalines / Sulfonamides / Benzimidazoles / Carbamates / Viral Nonstructural Proteins / Hepacivirus / Drug Resistance, Viral / Sofosbuvir Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2020 Type: Article